Verseon presents new efficacy results on oral diabetic macular edema drug candidate at ARVO 2018
Verseon’s oral plasma kallikrein inhibitors successfully reduce retinal thickness and retinal leakage, two hallmarks of the…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.